Ownership history in Quarry LP · 6 quarters on record
This page tracks every 13F SEC filing in which Quarry LP reported a position in MOONLAKE IMMUNOTHERAPEUTICS (MLTX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | ADDED | 9,001 | +7,201 | +400.1% | 0.01% | $65K | $7.17 |
| 2025 Q2 | REDUCED | 1,800 | -600 | -25.0% | 0.02% | $85K | $47.20 |
| 2025 Q1 | REDUCED | 2,400 | -600 | -20.0% | 0.02% | $94K | $39.07 |
| 2024 Q2 | ADDED | 3,000 | +1,900 | +172.7% | 0.04% | $132K | $43.97 |
| 2024 Q1 | ADDED | 1,100 | +250 | +29.4% | 0.01% | $55K | $50.23 |
| 2023 Q4 | INITIATED | 850 | — | — | 0.01% | $51K | — |
As of 2025 Q4 — sorted by position size